Blockade of T‐cell receptor with Ig and ITIM domains elicits potent antitumor immunity in naturally occurring HBV‐related HCC in mice
Y Wu, X Hao, H Wei, R Sun, Y Chen, Z Tian - Hepatology, 2023 - journals.lww.com
Y Wu, X Hao, H Wei, R Sun, Y Chen, Z Tian
Hepatology, 2023•journals.lww.comHepatology AASLD Publications Hepatology Liver Transplantation Hepatology Communications
Clinical Liver Disease Log in or Register Subscribe to journalSubscribe Get new issue
alertsGet alerts AASLD Member? Login here Secondary Logo Journal Logo Advanced Search
Toggle navigation Subscribe Register Login HomeCurrently selected Browse Collections About
For Authors Resources AASLD Guidelines Submit an Article Advanced Search March 2023 -
Volume 77 - Issue 3 Previous Article Next Article Original Articles: Viral Hepatitis Blockade of …
Clinical Liver Disease Log in or Register Subscribe to journalSubscribe Get new issue
alertsGet alerts AASLD Member? Login here Secondary Logo Journal Logo Advanced Search
Toggle navigation Subscribe Register Login HomeCurrently selected Browse Collections About
For Authors Resources AASLD Guidelines Submit an Article Advanced Search March 2023 -
Volume 77 - Issue 3 Previous Article Next Article Original Articles: Viral Hepatitis Blockade of …
Conclusions:
Blockade of TIGIT alone enhanced the antitumor activity of CD8+ T cells during the progression of HBV‐related HCC in a spontaneous HCC mouse model.
Lippincott Williams & Wilkins